ADAGIO MEDICAL HOLDINGS, INC. Costs and Expenses
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Costs and Expenses of $4.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for the quarter ending 2026-06-30 was $4.93M, a 4.60% increase year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for the quarter ending 2026-03-31 was $5.20M, a 29.70% decline year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for the quarter ending 2025-12-31 was $3.97M.
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for the quarter ending 2025-09-30 was $5.72M.
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for fiscal 2025 was $21.89M.
- ADAGIO MEDICAL HOLDINGS, INC. costs and expenses for fiscal 2023 was $28.24M.
| Period end | Costs and Expenses 1 month | Costs and Expenses 2 month | Costs and Expenses 3 month | Costs and Expenses 5 month | Costs and Expenses 6 month | Costs and Expenses 7 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.93M 10-Q · filed 2026-08-11 | $10.13M 10-Q · filed 2026-08-11 | $14.10M derived: sum of 3 quarters · filed 2026-08-11 | $19.82M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $5.20M 10-Q · filed 2026-05-12 | $9.17M derived: sum of 2 quarters · filed 2026-05-12 | $14.89M derived: sum of 3 quarters · filed 2026-05-12 | $19.61M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $9.69M derived: sum of 2 quarters · filed 2026-03-27 | $14.41M derived: sum of 3 quarters · filed 2026-08-11 | $21.89M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $5.72M 10-Q · filed 2025-11-12 | $10.44M derived: sum of 2 quarters · filed 2026-08-11 | $17.92M 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | $4.72M 10-Q · filed 2026-08-11 | $12.20M 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | $7.40M 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | $62.75M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $4.56M 10-Q · filed 2025-11-12 | |||||||
| 2024-07-30 | $6.26M 10-Q · filed 2025-11-12 | $22.01M 10-K · filed 2026-03-27 | ||||||
| 2024-06-30 | $6.91M 10-Q · filed 2025-08-14 | $15.75M 10-Q · filed 2025-08-14 | $21.16M derived: sum of 3 quarters · filed 2025-08-14 | $30.29M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $8.84M 10-Q · filed 2025-05-15 | $14.25M derived: sum of 2 quarters · filed 2025-05-15 | $23.37M derived: sum of 3 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $14.53M derived: sum of 2 quarters · filed 2025-03-27 | $28.24M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $9.12M 10-Q · filed 2024-11-14 | $22.83M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |